- Home
- ETON vs ITRG Comparison
ETON vs ITRG Comparison
Compare ETON & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | ITRG |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.8M | 482.5M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ETON | ITRG |
|---|---|---|
| Price | $16.45 | $4.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $29.67 | $4.13 |
| AVG Volume (30 Days) | 269.3K | ★ 1.7M |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | $70,316,000.00 | ★ $219,125,000.00 |
| Revenue This Year | $113.27 | $1,016.77 |
| Revenue Next Year | $36.70 | $7.81 |
| P/E Ratio | ★ N/A | $51.12 |
| Revenue Growth | ★ 102.77 | N/A |
| 52 Week Low | $11.09 | $0.79 |
| 52 Week High | $23.00 | $4.40 |
Technical Indicators
Market Signals| Indicator | ETON | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 70.50 |
| Support Level | $15.75 | $4.01 |
| Resistance Level | $17.19 | $4.40 |
| Average True Range (ATR) | 0.70 | 0.22 |
| MACD | 0.07 | 0.03 |
| Stochastic Oscillator | 60.58 | 97.10 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.